This study is currently not recruiting participants.

Protocol No. 0000498: Absorption and Safety with Sustained Use of Relizorb Evaluation (ASSURE) Study in Patients with Cystic Fibrosis Receiving Enteral Feeding

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to see if using Relizorb improves fat absorption in patients with CF and EPI and is safe and tolerable as part of an enteral feeding regimen.

Detailed description of study

The purpose of this study is to see if using Relizorb improves fat absorption in patients with CF and EPI and is safe and tolerable as part of an enteral feeding regimen.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: cystic fibrosis,exocrine pancreatic insufficiency
  • Age: 100 years or below
  • Gender: All
Updated on 12 Sep 2016. Study ID: 1607758327

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team